Company News
Earnings Season Splits Big Tobacco: Smoke-Free Pivoters Win While Laggards Slip
Second-quarter 2026 results are in for the world's biggest tobacco companies, and they tell a strikingly divided story. The companies leaning hardest into smoke-free products are raising their targets; the ones still anchored to traditional formats are stumbling. It's the clearest earnings-season snapshot yet of an industry splitting into winners and laggards along a single line: how fast each is moving away from combustion.
Altria: A Miss Dragged by Oral Tobacco
Altria, the U.S. giant behind Marlboro, fell short of Wall Street's expectations. It posted adjusted earnings of $1.48 per share — up a modest 2.8% from a year earlier, but below the roughly $1.50 analysts wanted. The soft spot was oral tobacco, where net revenues dropped 5.3% to $713 million and segment profit fell about 8% for the quarter, hurt by tough year-earlier comparisons and heavy spending behind its on! PLUS line.
There were bright spots — pricing power kept smokeable margins near 65% even as cigarette volumes declined — but the market focused on the miss, and the company narrowed its full-year guidance. This trend mirrors findings in the Smokeless Products Emerge as Only Growing Segment in 2026 Nicotine Market report.
BAT: Raising the Target on Velo's Surge
The contrast with British American Tobacco was sharp. BAT lifted its annual profit-growth forecast, now guiding toward the middle of its 5%–8% range rather than the low end. The driver was new categories, which climbed to nearly 20% of group revenue — led by a 66% jump in Velo modern-oral pouches and a return to double-digit growth for its Vuse products in the U.S. Strong American momentum more than offset a sharp decline in Asia.
ITC and JT: Two More Sides of the Split
The divide showed up globally. In India, ITC's profit dropped as a cigarette tax increase squeezed its core combustible business — a reminder of how heavily taxes weigh on traditional products. Meanwhile, Japan Tobacco reported its heated-tobacco Ploom volumes surging about 43.5%, with cigarettes serving as the cash-generating anchor funding that transition. This shift is similar to how the FDA Renews IQOS Authorizations has impacted the U.S. market.
The Pattern of Next-Gen Growth
Line the results up and the theme is unmistakable: momentum is concentrated in smoke-free and next-generation categories. Pouches and heated products are lifting the companies that have scaled them, while combustible and legacy-oral businesses face volume declines, tax pressure, and tougher competition. The quarter didn't create this shift — but it put a clear scoreboard on it.
A necessary caveat: strong sales are a commercial signal, not a health one. Whether combustible or smoke-free, these are addictive nicotine products intended only for adults, and "growing fast" says nothing about "safe."
What It Means for Shoppers and Retailers
For shoppers, the earnings divide helps explain what you see at the counter: continued price increases on cigarettes (companies protecting margins as volumes fall) alongside aggressive investment, promotion, and new variety in ZYN Black Cherry Nicotine Pouches and other smoke-free options. For retailers, it reinforces where the industry is putting its money — and where future selection and marketing will keep expanding. This shift is also being seen in the Cigarillos & Small Cigars market, where brands are diversifying their offerings.
The Bottom Line
Q2 2026 drew a bright line through Big Tobacco: BAT and Japan Tobacco riding smoke-free momentum, Altria and ITC pressured by their traditional cores. The takeaway isn't about any one stock — it's that the industry's growth has decisively moved toward non-combustible products, and the quarter's winners and losers were sorted almost entirely by how far down that road each company has traveled. For more industry updates, visit our Tobacco Guide: Pipe Tobacco, Wraps, Cigarillos & Pouches — All Articles.